Aspen Aerogels (NYSE:ASPN) Stock Price Up 7.2%

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) traded up 7.2% during trading on Tuesday . The stock traded as high as $16.32 and last traded at $16.27. 90,570 shares were traded during trading, a decline of 91% from the average session volume of 956,775 shares. The stock had previously closed at $15.18.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Roth Mkm assumed coverage on shares of Aspen Aerogels in a research report on Wednesday, March 6th. They set a "buy" rating and a $22.00 price target for the company. Canaccord Genuity Group raised their price target on shares of Aspen Aerogels from $13.00 to $17.00 and gave the stock a "buy" rating in a research report on Wednesday, December 27th. Canaccord Genuity Group raised their price target on shares of Aspen Aerogels from $13.00 to $17.00 and gave the stock a "buy" rating in a research report on Wednesday, December 27th. TheStreet raised shares of Aspen Aerogels from a "d+" rating to a "c-" rating in a research report on Wednesday, March 6th. Finally, HC Wainwright reaffirmed a "buy" rating and set a $20.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, February 14th. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.00.

Aspen Aerogels Stock Up 9.6 %

The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -25.21 and a beta of 2.04. The business's 50 day moving average price is $16.52 and its 200 day moving average price is $13.15. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.91 and a current ratio of 3.41.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 19.19% and a negative return on equity of 10.47%. The firm had revenue of $84.22 million for the quarter, compared to analysts' expectations of $83.82 million. During the same quarter last year, the company earned ($0.20) EPS. On average, equities analysts forecast that Aspen Aerogels, Inc. will post -0.24 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Federated Hermes Inc. boosted its stake in Aspen Aerogels by 53.9% during the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company's stock worth $18,211,000 after purchasing an additional 404,042 shares during the last quarter. Rice Hall James & Associates LLC boosted its stake in Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company's stock worth $5,359,000 after purchasing an additional 494,662 shares during the last quarter. Vanguard Group Inc. boosted its stake in Aspen Aerogels by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company's stock worth $29,635,000 after purchasing an additional 14,013 shares during the last quarter. Principal Financial Group Inc. acquired a new stake in Aspen Aerogels during the 3rd quarter worth $449,000. Finally, Maven Securities LTD acquired a new stake in Aspen Aerogels during the 3rd quarter worth $860,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.